1-5 of 5
Katja Weisel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX

Clinical Trials & Observations
Andrew Spencer, Philippe Moreau, Maria-Victoria Mateos, Hartmut Goldschmidt, Kenshi Suzuki, Mark-David Levin, Pieter Sonneveld, Robert Z. Orlowski, Sung-Soo Yoon, Saad Z. Usmani, Katja Weisel, Donna Reece, Tahamtan Ahmadi, Huiling Pei, Wendy Garvin Mayo, Xue Gai, Jodi Carey, J. Blake Bartlett, Robin Carson, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2024) 8 (2): 388–398.
https://doi.org/10.1182/bloodadvances.2023010579
Published: 2024
Includes: Supplemental data
Journal Articles

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Clinical Trials & Observations
Saad Z. Usmani, Hang Quach, Maria-Victoria Mateos, Ola Landgren, Xavier Leleu, David Siegel, Katja Weisel, Xiaomei Shu, Chuang Li, Meletios Dimopoulos
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3739–3748.
https://doi.org/10.1182/bloodadvances.2023010026
Published: 2023
Includes: Supplemental data
Journal Articles

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Clinical Trials & Observations
Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann
Journal: Blood Advances
Blood Adv (2022) 6 (2): 515–520.
https://doi.org/10.1182/bloodadvances.2021005532
Published: 2022
Includes: Supplemental data
Journal Articles

Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients

Clinical Trials & Observations
Susanne Ghandili, Susanne Pfefferle, Kevin Roedl, Piet Sonnemann, Panagiotis Karagiannis, Olaf Boenisch, Stefan Kluge, Stefan Schmiedel, Harald Ittrich, Holger Rohde, Marc Lütgehetmann, Katja Weisel, Carsten Bokemeyer, Dominic Wichmann, Walter Fiedler, Dominik Jarczak, Franziska Modemann
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5936–5941.
https://doi.org/10.1182/bloodadvances.2020002543
Published: 2020
Journal Articles

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Thierry Facon, Ruben Niesvizky, Maria-Victoria Mateos, David Siegel, Cara Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5449–5459.
https://doi.org/10.1182/bloodadvances.2020001965
Published: 2020
Includes: Supplemental data